These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9330064)

  • 21. Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patients.
    Chibowska M; Krasowska D; Weglarz J
    Med Sci Monit; 2001; 7(2):282-8. PubMed ID: 11257736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R; Izzo F; Perrone F; Pignata S; Galati MG; Leonardi E; Castiglione F; Orlando R; Castello G; Esposito G; Gallo C; Daniele B
    Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum matrix metalloproteinase-3 in systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Arch Dermatol Res; 2004 Jun; 296(1):25-9. PubMed ID: 15095096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis.
    Terras S; Opitz E; Moritz RK; Höxtermann S; Gambichler T; Kreuter A
    Ann Rheum Dis; 2013 Jan; 72(1):144-5. PubMed ID: 22858587
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prolactin levels in patients with systemic scleroderma].
    Alekperov RT; Nasonov EL; Masenko VP; Guseva NG
    Klin Med (Mosk); 1998; 76(4):25-9. PubMed ID: 9613077
    [No Abstract]   [Full Text] [Related]  

  • 26. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    Carulli MT; Handler C; Coghlan JG; Black CM; Denton CP
    Ann Rheum Dis; 2008 Jan; 67(1):105-9. PubMed ID: 17604287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
    Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
    Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement.
    Manetti M; Guiducci S; Ceccarelli C; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Oct; 70(10):1876-8. PubMed ID: 21571732
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Takehara K; Sato S
    Ann Rheum Dis; 2004 May; 63(5):583-7. PubMed ID: 15082492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
    Hara T; Ogawa F; Yanaba K; Iwata Y; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K; Komura K; Kodera M; Matsushita T; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis.
    Ogawa F; Shimizu K; Muroi E; Hara T; Hasegawa M; Takehara K; Sato S
    Rheumatology (Oxford); 2006 Jul; 45(7):815-8. PubMed ID: 16449367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection.
    Tülek N; Saglam SK; Saglam M; Türkyilmaz R; Yildiz M
    Hepatogastroenterology; 2000; 47(33):828-31. PubMed ID: 10919040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis.
    Airò P; Bettinzioli M; Gorla R; Cattaneo R
    Ann Rheum Dis; 1991 Apr; 50(4):270-1. PubMed ID: 2029213
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased serum soluble OX40 in patients with systemic sclerosis.
    Komura K; Yoshizaki A; Kodera M; Iwata Y; Ogawa F; Shimizu K; Wayaku T; Yukami T; Murata M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2359-62. PubMed ID: 18843780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
    Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of soluble interleukin-2 receptor in systemic and circumscribed scleroderma.
    Zillikens D; Blum C; Dummer R; Hartmann AA; Burg G
    Dermatology; 1992; 184(3):233-4. PubMed ID: 1392125
    [No Abstract]   [Full Text] [Related]  

  • 40. Soluble interleukin-2 receptor: a new prognostic marker in lung cancer.
    Marino P; Buccheri G; Preatoni A; Ferrigno D; Cori P; Rosti A; Mozzi R; Moroni GA
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):151-4. PubMed ID: 2092110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.